Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2006-7-27
pubmed:abstractText
The objective was to improve efficacy of antisense phosphorodiamidate morpholino oligomers (PMOs) by improving their uptake into bacterial cells. Four different bacterium-permeating peptides, RFFRFFRFFXB, RTRTRFLRRTXB, RXXRXXRXXB, and KFFKFFKFFKXB (X is 6-aminohexanoic acid and B is beta-alanine), were separately coupled to two different PMOs that are complementary to regions near the start codons of a luciferase reporter gene (luc) and a gene required for viability (acpP). Luc peptide-PMOs targeted to luc inhibited luciferase activity 23 to 80% in growing cultures of Escherichia coli. In cell-free translation reactions, Luc RTRTRFLRRTXB-PMO inhibited luciferase synthesis significantly more than the other Luc peptide-PMOs or the Luc PMO not coupled to peptide. AcpP peptide-PMOs targeted to acpP inhibited growth of E. coli or Salmonella enterica serovar Typhimurium to various extents, depending on the strain. The concentrations of AcpP RFFRFFRFFXB-PMO, AcpP RTRTRFLRRTXB-PMO, AcpP KFFKFFKFFKXB-PMO, and ampicillin that reduced CFU/ml by 50% after 8 h of growth (50% inhibitory concentration [IC(50)]) were 3.6, 10.8, 9.5, and 7.5 microM, respectively, in E. coli W3110. Sequence-specific effects of AcpP peptide-PMOs were shown by rescuing growth of a merodiploid strain that expressed acpP with silent mutations in the region targeted by AcpP peptide-PMO. In Caco-2 cultures infected with enteropathogenic E. coli (EPEC), 10 microM AcpP RTRTRFLRRTXB-PMO or AcpP RFFRFFRFFXB-PMO essentially cleared the infection. The IC(50) of either AcpP RTRTRFLRRTXB-PMO or AcpP RFFRFFRFFXB-PMO in EPEC-infected Caco-2 culture was 3 microM. In summary, RFFRFFRFFXB, RTRTRFLRRTXB, or KFFKFFKFFXB, when covalently bonded to PMO, significantly increased inhibition of expression of targeted genes compared to PMOs without attached peptide.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-11283595, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-14506035, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-15004293, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-15616302, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-15844617, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-15872045, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-16029037, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-16048926, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-7016860, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-8144487, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-8655562, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-8843284, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870773-9212909
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2789-96
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16870773-Bacterial Proteins, pubmed-meshheading:16870773-Caco-2 Cells, pubmed-meshheading:16870773-Cell Survival, pubmed-meshheading:16870773-Colony Count, Microbial, pubmed-meshheading:16870773-Dose-Response Relationship, Drug, pubmed-meshheading:16870773-Escherichia coli, pubmed-meshheading:16870773-Escherichia coli Infections, pubmed-meshheading:16870773-Escherichia coli Proteins, pubmed-meshheading:16870773-Genes, Bacterial, pubmed-meshheading:16870773-Genes, Reporter, pubmed-meshheading:16870773-Humans, pubmed-meshheading:16870773-Inhibitory Concentration 50, pubmed-meshheading:16870773-Kinetics, pubmed-meshheading:16870773-Luciferases, pubmed-meshheading:16870773-Morpholines, pubmed-meshheading:16870773-Morpholinos, pubmed-meshheading:16870773-Mutation, pubmed-meshheading:16870773-Peptides, pubmed-meshheading:16870773-Salmonella typhimurium, pubmed-meshheading:16870773-Serotyping
pubmed:year
2006
pubmed:articleTitle
Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.
pubmed:affiliation
AVI BioPharma, Inc., Corvallis, Oregon, USA.
pubmed:publicationType
Journal Article, Comparative Study, In Vitro, Research Support, Non-U.S. Gov't